Neshima Medical

Neshima Medical is a preclinical stage therapeutic company, with a mission to reduce mortality rates and hospitalization days. Neshimas innovation is utilizing its patented liquid-foam therapy (LiFTTM) for respiratory drug delivery. The vision of the company is to treat severe pneumonia and asthma using existing small molecules, COPD using topical cell therapy, IPF using slow-release particles, CF using gene therapy, and more. LiFTTM enables for the first-time topical and fast administration of high doses of therapeutics throughout the lungs, and through constricted and mucus obstructed airways, including cells and large size particles (10 compared to nebulizers, over 50 m)

Neshima medical operates in the Pharmaceutical manufacturing industry.

Neshima medical's revenue is 11m - 100m

Neshima medical has 11 - 50 employees.